Estimations des analystes de Wall Street pour Arcutis Biotherapeutics, Inc. (ARQT): objectif de cours de consensus, recommandations achat/conserver/vente et prévisions de revenus, BPA et EBITDA pour les prochains exercices.
Surprises de Résultats Récentes
| Date | BPA Réel | BPA Estimé | vs Est. |
|---|---|---|---|
| 2026-10-27 | $0.17 | ||
| 2026-08-05 | $0.11 | $0.06 | +99.7% |
| 2026-05-06 | $-0.09 | $-0.02 | -350.0% |
| 2026-02-25 | $0.13 | $0.03 | +333.3% |
| 2025-10-28 | $0.06 | $-0.10 | +160.0% |
| 2025-08-06 | $-0.13 | $-0.18 | +27.8% |
| 2025-05-06 | $-0.20 | $-0.21 | +4.8% |
| 2025-02-25 | $-0.09 | $-0.28 | +67.9% |
Ratios de valorisation
| Ratio P/E | 116.28 |
| Prix / Valeur comptable | 15.19 |
| EV / EBITDA | 1475.09 |
| Rendement du dividende | 0.00% |
Compte de Résultat (10 ans)
| Année | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Revenus | 0 | 0 | 0 | 0 | 0 | $3.7M | $59.6M | $196.5M | $376.1M |
| Coût des Ventes | 0 | 0 | $195000 | $455000 | $763000 | $754000 | $5.0M | $19.1M | $36.7M |
| Marge Brute | 0 | 0 | -$195000 | -$455000 | -$763000 | $2.9M | $54.6M | $177.4M | $339.4M |
| R&D | $3.4M | $17.9M | $36.5M | $115.3M | $145.6M | $182.4M | $110.6M | $76.4M | $77.1M |
| Frais Généraux | $695000 | $1.8M | $6.4M | $20.9M | $61.0M | $122.1M | $185.1M | $229.4M | $274.6M |
| Charges Opérationnelles | $4.1M | $19.7M | $42.9M | $136.2M | $205.8M | $304.6M | $295.7M | $305.8M | $351.6M |
| Résultat Opérationnel | -$4.1M | -$19.7M | -$43.1M | -$136.6M | -$206.5M | -$301.6M | -$241.1M | -$128.4M | -$12.2M |
| EBITDA | -$872000 | $480000 | -$41.8M | -$135.2M | -$205.6M | -$294.6M | -$227.4M | -$109.6M | $2.5M |
| Charges d'Intérêt | 0 | 0 | 0 | 0 | 0 | $15.7M | $29.7M | $27.2M | $12.1M |
| Résultat Avant Impôts | -$5.0M | -$19.3M | -$42.0M | -$135.7M | -$206.4M | -$311.5M | -$259.0M | -$139.4M | -$15.0M |
| Impôts | 0 | 0 | 0 | 0 | 0 | 0 | $3.1M | $647000 | $1.2M |
| Résultat Net | -$5.0M | -$19.3M | -$42.0M | -$135.7M | -$206.4M | -$311.5M | -$262.1M | -$140.0M | -$16.1M |
| BPA | $-4.71 | $-0.53 | $-1.10 | $-3.80 | $-4.17 | $-5.66 | $-3.78 | $-1.16 | $-0.13 |
| BPA Dilué | $-4.71 | $-0.53 | $-1.10 | $-3.80 | $-4.17 | $-5.66 | $-3.78 | $-1.16 | $-0.13 |
| Actions en Circulation (Diluées) | $1.1M | $36.2M | $38.1M | $35.7M | $49.4M | $55.0M | $69.3M | $121.0M | $127.2M |
Prix
| Prix | $26.14 |
| Capitalisation | $3.3B |
| Bourse | NASDAQ |
| Pays | US |
Entreprises liées: CELC · CGON · CNTA · FOLD · IRON · LEGN · TARS
Explorer le secteur: Healthcare · Biotechnology
Plus de sections de ARQT: Vue d'ensemble · Financiers · Valorisation · Statistiques · Technique · Actionnariat · Actualités · Événements
Découvrir plus: Radar — signaux d'actions sous-évaluées · Académie d'Investissement — apprenez à analyser les actions